| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 06/25/2009 | WO2009078366A1 α-LIPOIC ACID NANOPARTICLE AND METHOD FOR PRODUCING THE SAME |
| 06/25/2009 | WO2009077850A1 Antimicrobial composition comprising an extract from cyclopia |
| 06/25/2009 | WO2009077584A1 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 06/25/2009 | WO2009076869A1 Salvianolic acid of high purity, preparation method and use thereof |
| 06/25/2009 | WO2009060013A3 A method for treating ailments of the oral cavity with a krill enzyme composition |
| 06/25/2009 | WO2009041705A3 5-membered heterocyclic compounds as proton pump inhibitors |
| 06/25/2009 | WO2009040445A3 Arabinoxylo-oligosaccharides useful against gastrointestinal infections |
| 06/25/2009 | WO2008067257A8 Inhibitors of diacylglycerol o-acyltransferase type 1 enzyme |
| 06/25/2009 | US20090163593 Phenylalkylene-substituted or allyloxyphenylmethyl-substituted, e.g., N-(p-allyloxybenzyl-N-(2-methoxyethyl)-N-(3-phenylallyl)amine; endocannabinoid agonists; pain, Parkinson's disease, multiple sclerosis, or Huntington's chorea; asthma |
| 06/25/2009 | US20090163580 Anti-aging composition containing resveratrol and method of administration |
| 06/25/2009 | US20090163553 Benzimidazole compound crystal |
| 06/25/2009 | US20090163542 5-ht7 receptor antagonists |
| 06/25/2009 | US20090163539 Enantiomer of tenatoprazole and the use thereof in therapy |
| 06/25/2009 | US20090163530 adapted to adhere to and dissolve in a mouth of a consumer include a water soluble film-forming polymer pullulan, antimicrobially effective amounts of essential oils thymol, methyl salicylate, eucalyptol and menthol; for killing plaque-producing germs that cause dental plaque, bad breath, gingivitis |
| 06/25/2009 | US20090163505 Amino-heteroaryl-containing prokineticin 1 receptor antagonists |
| 06/25/2009 | US20090163495 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |
| 06/25/2009 | US20090163460 Diagnostics and therapeutics for early-onset menopause |
| 06/25/2009 | US20090163459 Use of 24-nor-UDCA |
| 06/25/2009 | US20090163427 Pharmaceutical Composition of Enterosorbent and Prebiotics, Dosage Forms, and the Method for Prevention and Treatment of Gastrointestinal Disorders |
| 06/25/2009 | US20090163423 Exendins and Exendin Agonist Analogs to Regulate Gastrointestinal Motility |
| 06/25/2009 | US20090163413 Dental products comprising bone growth enhancing peptide |
| 06/25/2009 | US20090162455 Feed for fish |
| 06/25/2009 | US20090162339 drug delivery of an enzyme such as erythromycin esterase or beta-lactamase capable of deactivating a beta -lactam, macrolide, or quinolone antibiotic; reducing the concentration of an antibiotic in the colon; ulcerative colitis or Crohn's disease |
| 06/25/2009 | US20090162323 Method for Stimulating the Intestinal Flora |
| 06/25/2009 | US20090162322 Oral administration form comprising probiotic bacteria |
| 06/25/2009 | US20090162297 Buccal, polar and non-polar spray containing ondansetron |
| 06/25/2009 | DE102008062373A1 Mittel, mit mindestens einem Wirkstoff, der eine Zahnfleischwachstumswirkung aufweist Means, with at least one active ingredient that comprises a gum growth effect |
| 06/25/2009 | DE102008039271A1 Neuer Mariendistelextrakt, Verfahren zur Herstellung und Verwendung New milk thistle extract, methods of preparation and use |
| 06/25/2009 | CA2709119A1 Preventive or therapeutic agent for inflammatory bowel diseases |
| 06/25/2009 | CA2707010A1 .alpha.-lipoic acid nanoparticles and methods for preparing thereof |
| 06/24/2009 | EP2072623A1 Screening method for prokinetic agent |
| 06/24/2009 | EP2072519A1 Diaryl ketimine derivative |
| 06/24/2009 | EP2072053A1 Method for decreasing abdominal girth by administering a bifidobacterium bacteria |
| 06/24/2009 | EP2072050A1 Compounds with anti-emetic effect |
| 06/24/2009 | EP1951261A4 Compositions and methods for treating inflammatory disorders |
| 06/24/2009 | EP1499746A4 Method to inhibit cell growth using oligonucleotides |
| 06/24/2009 | EP1339709B1 Farnesyl transferase inhibiting benzoheterocyclic derivatives |
| 06/24/2009 | EP1284977B1 Thienodibenzoazulene compounds as tumor necrosis factor inhibitors |
| 06/24/2009 | CN101461804A (+)-1-(3,4-dichlorrophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereof |
| 06/24/2009 | CN100503608C Deazapurines and uses thereof |
| 06/24/2009 | CN100503599C Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 06/24/2009 | CN100503598C Improved chemical process and pharmaceutical formulation |
| 06/24/2009 | CN100503596C Process for purifying 6-methoxy omeprazole |
| 06/24/2009 | CN100503574C Substituted ideno[1,2-c]isoquinoline derivatives and methods of use thereof |
| 06/24/2009 | CN100503572C Caspase inhibitors and uses thereof |
| 06/24/2009 | CN100503570C Cyanoguanidine prodrugs |
| 06/24/2009 | CN100503560C Substituted cyclohexane derivatives |
| 06/24/2009 | CN100502923C Anticulcer herbal composition |
| 06/24/2009 | CN100502912C Medicine for treating deficiency syndrome, its preparing process and usage |
| 06/24/2009 | CN100502903C Anshenning dripping pill for treating neurosism and its preparing method |
| 06/24/2009 | CN100502902C Honeysuckle and baical skullcap root combination, oral preparation and injection preparation containing same, its preparing method and application |
| 06/24/2009 | CN100502900C Astragalus root dripping pill and its preparing method |
| 06/24/2009 | CN100502899C Inspection method for Chinese medicinal composition for treating blood and qi depletion,irregular menstruation |
| 06/24/2009 | CN100502893C Strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it |
| 06/24/2009 | CN100502889C Oral and dental composition |
| 06/24/2009 | CN100502888C Lipoteichoic acid from lactic acid bacteria and its use to modulate immune responses mediated by gram-negative, potentially pathogenic gram-positive bacteria |
| 06/24/2009 | CN100502863C 2,4,5-trisubstituded thiazolyl derivatives and their anti-inflammatory activity |
| 06/23/2009 | USRE40793 treating conditions related to impairment of gastric emptying, gastromotility disorders; superior gastrokinetic properties; e.g. trans-4-amino-N-[(1-butyl-3-hydroxy-4-piperidinyl)methyl]-5-chloro-2,3-dihydro-7-benzofurancarboxamide |
| 06/23/2009 | USRE40792 treating CANCER, PMS, MENOPAUSE AND HYPERCHOLESTEROLEMIA with plant extract of soya or clover and isoflavones from Genistein, Daidzein, Biochanin A, Formononetin or the natural glycosides; dosage forms |
| 06/23/2009 | US7550494 Small molecules useful in the treatment of inflammatory disease |
| 06/23/2009 | US7550489 N-[3-(4-chlorophenyl)-2-(3-cyanophenyl)-1-methylpropyl]-2-(5-trifluoromethyl-2-pyridyloxy)-2-methylpropanamide and phentermine, metformin, or bupropion; obesity; antipsychotic agents; synergistic; cannabinoid receptor antagonists |
| 06/23/2009 | US7550476 Condensed polycyclic compounds |
| 06/23/2009 | US7550475 Use of phosphodiesterase 4 inhibitors such as 6,7-dimethoxy-1-[2-(1,3-dioxocyclohexan-2-yl)pyridin-4-yl]-2,3-bis(hydroxymethyl)naphthalene to treat asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550464 Use of phosphodiesterase 4 inhibitors such as 8,9-dimethoxy-6-phenyl-1,3,4,6,11,11a-hexahydro-2H -pyrazino[1,2-b]isoquinoline for treating asthma, chronic obstructive pulmonary disease, atopic dermatitis, allergic rhinitis, psoriasis, rheumatoid arthritis, septic shock, ulcerative colitis |
| 06/23/2009 | US7550460 2,4-pyrimidinediamine compounds and their uses |
| 06/23/2009 | US7550437 administering a protein agonist for protease-activated receptor (PAR-2); side effects reduction; peptidase inhibitors (amistatins); drug delivery; biodrugs as antisecretory agents |
| 06/23/2009 | US7550147 Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (MVA) |
| 06/23/2009 | CA2492804C Novel inhibitors of kinases |
| 06/23/2009 | CA2449874C New indole derivatives with 5-ht6 receptor affinity |
| 06/23/2009 | CA2393135C Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 06/23/2009 | CA2389219C Dry powder compositions having improved dispersivity |
| 06/23/2009 | CA2373852C Oligosaccharide aldonic acids and their topical use |
| 06/23/2009 | CA2252535C A pharmaceutical formulation containing growth hormone, an amino acid and a non-ionic detergent |
| 06/23/2009 | CA2208078C Formulations and methods for reducing skin irritation |
| 06/23/2009 | CA2139100C New sequences of hepatitis c virus genotypes and their use as therapeutic and diagnostic agents |
| 06/18/2009 | WO2009076593A1 Modulators of cystic fibrosis transmembrane conductance regulator |
| 06/18/2009 | WO2009076408A2 3 -carboxypropyl-aminotetralin derivatives as mu opioid receptor antagonists |
| 06/18/2009 | WO2009076399A2 Aminotetralin compounds as mu opioid receptor antagonists |
| 06/18/2009 | WO2009076195A1 Treatment of drug-induced nausea with opioid antagonists |
| 06/18/2009 | WO2009075573A1 Paediatric fibre mixture |
| 06/18/2009 | WO2009075564A1 Paediatric fibre mixture |
| 06/18/2009 | WO2009075349A1 Element retained in blood showing degradability selectively in tumor tissue |
| 06/18/2009 | WO2009075277A1 4-aminopyrimidine derivative and medicinal composition containing the compound |
| 06/18/2009 | WO2009075216A1 Therapeutic agent for ulcer |
| 06/18/2009 | WO2009074792A2 Substituted benzoquinones and hydroquinones in the treatment of periodontal diseases |
| 06/18/2009 | WO2009074320A1 Method for odor extinction |
| 06/18/2009 | WO2009074246A1 Novel 2-hetaryl thiazole-4-carboxamide derivatives, production thereof, and use thereof as a medicament |
| 06/18/2009 | WO2009049013A9 Cholera vaccines |
| 06/18/2009 | US20090156652 Therapeutic agent for food competence disorder in stomach |
| 06/18/2009 | US20090156622 2,4-pyrimidinediamine compounds and their uses |
| 06/18/2009 | US20090156598 Imidazolopyrimidine modulators of TRPV1 |
| 06/18/2009 | US20090156589 1,2-di(cyclic group)substituted benzene derivative |
| 06/18/2009 | US20090156528 RNA INTERFERENCE MEDIATED INHIBITION OF HEPATITIS C VIRUS (HCV) GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 06/18/2009 | US20090156493 Urocortin-iii and uses thereof |
| 06/18/2009 | US20090156490 Peptides for diagnostic and therapeutic methods for celiac sprue |
| 06/18/2009 | US20090156465 Derivatives of beta-amino acid as dipeptidyl peptidase-iv inhibitors |
| 06/18/2009 | US20090155906 Cell differentiation suppressing agent, method of culturing cells using the same, culture solution, and cultured cell line |
| 06/18/2009 | US20090155370 Methods and compositions for selectively removing potassium ion from the gastrointestinal tract of a mammal |
| 06/18/2009 | US20090155368 Pharmaceutical compositions |
| 06/18/2009 | US20090155281 Methods of using antibodies that bind both bcma and taci |